류마티스 다발근통의 진단과 치료
Diagnosis and Treatment of Polymyalgia Rheumatica
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that usually affects adults over 50 years of age. It is characterizedby pain and stiffness of the neck, shoulders and hips. Laboratory tests have shown marked elevation of acute phase reactants(ESR and CRP), but there is no specific test to diagnose PMR. Recently, the European League Against Rheumatism and theAmerican College of Rheumatology jointly proposed a new set of classification criteria for PMR. The mainstay of PMR treatmentis low-dose glucocorticoids (prednisolone 10-20 mg/day). patients with PMR usually respond very well to steroid therapy within afew days to one week, but will often relapse despite treatment.
Abstract
Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that usually affects adults over 50 years of age. It is characterizedby pain and stiffness of the neck, shoulders and hips. Laboratory tests have shown marked elevation of acute phase reactants(ESR and CRP), but there is no specific test to diagnose PMR. Recently, the European League Against Rheumatism and theAmerican College of Rheumatology jointly proposed a new set of classification criteria for PMR. The mainstay of PMR treatmentis low-dose glucocorticoids (prednisolone 10-20 mg/day). patients with PMR usually respond very well to steroid therapy within afew days to one week, but will often relapse despite treatment.
참고문헌 (24)
- Chuang TY, "Polymyalgia rheumatica: a 10-year epidemiologic and clinical study", Ann Intern Med, 97, pp.672~680 (1982)
- Kermani TA, "Polymyalgia rheumatica", Lancet, 381, pp.63~72 (2013)
- Elling P, "Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection", J Rheumatol, 23, pp.112~119 (1996)
- Smeeth L, "Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001", Ann Rheum Dis, 65, pp.1093~1098 (2006)
- Perfetto F, "Seasonal pattern in the onset of polymyalgia rheumatica", Ann Rheum Dis, 64, pp.1662~1663 (2005)
- Weyand CM, "HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis", Arthritis Rheum, 37, pp.514~520 (1994)
- Cid MC, "Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen", Arthritis Rheum, 31, pp.678~682 (1988)
- Gonzalez-Gay MA, "Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica", Semin Arthritis Rheum, 33, pp.38~48 (2003)
- Salvarani C, "Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study", Arthritis Rheum, 41, pp.1221~1226 (1998)
- Caporali R, "Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study", Ann Rheum Dis, 60, pp.1021~1024 (2001)
- Dasgupta B, "2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism", American College of Rheumatology collaborative initiative, 2012, pp.64, 943~954
- Muller S, "Is cancer associated with polymyalgia rheumatica? a cohort study in the General Practice Research Database", Ann Rheum Dis (2013)
- Healey LA, "Long-term follow-up of polymyalgia rheumatica: evidence for synovitis", Semin Arthritis Rheum, 13, pp.322~328 (1984)
- Hernandez-Rodriguez J, "Treatment of polymyalgia rheumatica: a systematic review", Arch Intern Med, 169, pp.1839~1850 (2009)
- Kremers HM, "Relapse in a population based cohort of patients with polymyalgia rheumatica", J Rheumatol, 32, pp.65~73 (2005)
- Gabriel SE, "Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica", Arthritis Rheum, 40, pp.1873~1878 (1997)
- Caporali R, "Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial", Ann Intern Med, 141, pp.493~500 (2004)
- Cimmino MA, "Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids", Clin Exp Rheumatol, 26, pp.395~400 (2008)
- Van der Veen MJ, "Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis", Ann Rheum Dis, 55, pp.218~223 (1996)
- Salvarani C, "Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial", Ann Intern Med, 146, pp.631~639 (2007)
- Macchioni P, "Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature", Semin Arthritis Rheum, 43, pp.113~118 (2013)
- Salvarani C, "Acute-phase reactants and the risk of relapse", recurrence in polymyalgia rheumatica: a prospective followup study, 2005, pp.53, 33~38
- Salvarani C, "Polymyalgia rheumatica and giant-cell arteritis", N Engl J Med, 347, pp.261~271 (2002)
- Ayoub WT, "Polymyalgia rheumatica: duration of therapy and long-term outcome", Am J Med, 79, pp.309~315 (1985)